NAMS Stock Ownership Activity
NEWAMSTERDAM PHARMA CO NV 13F holders
No value investing guru has made any change to the NEWAMSTERDAM PHARMA CO NV (NAMS) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying NAMS now?
According to the latest SEC filing(s) NEWAMSTERDAM PHARMA CO NV (NAMS) has not been purchased by any super investor.
To see more about who is investing in NEWAMSTERDAM PHARMA CO NV (NAMS), please go to the NAMS ownership page.
2023 Q3
(1 result)
Current price: $21.81
135.78%
Reported price*: $9.25
2023 Q2
(1 result)
Current price: $21.81
83.43%
Reported price*: $11.89
2023 Q1
(1 result)
Current price: $21.81
62.28%
Reported price*: $13.44
2022 Q4
(1 result)
Current price: $21.81
107.32%
Reported price*: $10.52
4 of 4
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.